Aledade hits $123 million for value-based care and more digital funds for health
Aledade, Partnering with primary care providers to build responsible care organizations with technology, has raised $123 million in a Series E funding round led by OMERS Growth Equity.
Other participants in the round include Fidelity Management and Research and other existing investors. The capital raise brings the startup’s valuation to $3.1 billion, as reported by Insider.
Aledade said it plans to use the funding to focus on providing more value-based care arrangements for Medicare Advantage-covered seniors and expand services under the plan. new medical service subsidiary Aledade Care Solutions.
The company announced a $100 Million Series EASY in January 2021 and a $64 million Series C in April 2020.
“When we founded Aledade nearly a decade ago, we made a bet that if we empower primary care physicians with the right insights, technology, and valuable contracts, we can improve patient outcomes, cut wasteful spending, and create a scalable business model for these practices, and Aledade to thrive,” said CEO and co-founder. founder, Dr. Farzad Mostashari said in a statement.
“With this funding, Aledade is extremely well positioned in this market environment to accelerate our work to accommodate patients anywhere, particularly at Medicare Advantage, and seize the opportunity. to expand its comprehensive patient care offerings. Challenging market conditions may present a unique opportunity for business to become stronger, and that is our plan.”
Drug discovery platform Drugs Insilico scored $60 million in Series D funding.
The round included participation from BHR Partners as well as previous investors Warburg Pincus, B Capital Group, Qiming Venture Partners, BOLD Capital Partners and Pavilion Capital. The company’s founder and CEO Alex Zhavoronkov also invested in Series D.
Insilico will use this money to advance product pipeline, develops drug discovery engine Pharma.AI and expands globally. The company announced a Series C funding round $225 million in June of last year.
Women’s health-focused virtual wellness startup Visana Health has completed a $2.6 million seed round, as reported by Minne Inno.
Seeds include participation from Flare Capital Partners, Pixel Perfect Ventures, InHealth Ventures, SWL Healthcare Ventures and angel investors. The startup will use this funding to supplement women’s health services and launch a pilot program with a national health plan to study the effectiveness of its tools.
Choixa telemedicine clinic for reproductive care, has raised $1 million in seed funding led by Elevate Capital.
The startup, which offers medical abortions, emergency contraception, birth control, genital herpes care, herpes treatment and UTIs, says it plans to raise an additional 500,000 to $1 million in the coming months.
“We’re incredibly grateful to Elevate for believing in our mission to improve access to safe abortion care at home,” CEO and co-founder Cindy Adam said in a statement. An announcement. “We are passionate about our ability to grow our team of clinicians and expand operations in other states at a critical time, when access to fertility is increasingly at risk.”